Cargando…

Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress

Tuberous sclerosis complex (TSC) is a congenital disorder characterized by cortical malformations and concomitant epilepsy caused by loss‐of‐function mutations in the mTOR suppressors TSC1 or TSC2. While the underlying molecular changes caused by mTOR activation in TSC have previously been investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmer, Till S., Korotkov, Anatoly, Zwakenberg, Susan, Jansen, Floor E., Zwartkruis, Fried J. T., Rensing, Nicholas R., Wong, Michael, Mühlebner, Angelika, van Vliet, Erwin A., Aronica, Eleonora, Mills, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412124/
https://www.ncbi.nlm.nih.gov/pubmed/33786950
http://dx.doi.org/10.1111/bpa.12949
_version_ 1783747396565467136
author Zimmer, Till S.
Korotkov, Anatoly
Zwakenberg, Susan
Jansen, Floor E.
Zwartkruis, Fried J. T.
Rensing, Nicholas R.
Wong, Michael
Mühlebner, Angelika
van Vliet, Erwin A.
Aronica, Eleonora
Mills, James D.
author_facet Zimmer, Till S.
Korotkov, Anatoly
Zwakenberg, Susan
Jansen, Floor E.
Zwartkruis, Fried J. T.
Rensing, Nicholas R.
Wong, Michael
Mühlebner, Angelika
van Vliet, Erwin A.
Aronica, Eleonora
Mills, James D.
author_sort Zimmer, Till S.
collection PubMed
description Tuberous sclerosis complex (TSC) is a congenital disorder characterized by cortical malformations and concomitant epilepsy caused by loss‐of‐function mutations in the mTOR suppressors TSC1 or TSC2. While the underlying molecular changes caused by mTOR activation in TSC have previously been investigated, the drivers of these transcriptional change have not been fully elucidated. A better understanding of the perturbed transcriptional regulation could lead to the identification of novel pathways for therapeutic intervention not only in TSC, but other genetic epilepsies in which mTOR activation plays a key role, such as focal cortical dysplasia 2b (FCD). Here, we analyzed RNA sequencing data from cortical tubers and a tsc2(−/−) zebrafish. We identified differential expression of the transcription factors (TFs) SPI1/PU.1, IRF8, GBX2, and IKZF1 of which SPI1/PU.1 and IRF8 targets were enriched among the differentially expressed genes. Furthermore, for SPI1/PU.1 these findings were conserved in TSC zebrafish model. Next, we confirmed overexpression of SPI1/PU.1 on the RNA and protein level in a separate cohort of surgically resected TSC tubers and FCD tissue, in fetal TSC tissue, and a Tsc1 (GFAP−/−) mouse model of TSC. Subsequently, we validated the expression of SPI1/PU.1 in dysmorphic cells with mTOR activation in TSC tubers. In fetal TSC, we detected SPI1/PU.1 expression prenatally and elevated RNA Spi1 expression in Tsc1 (GFAP−/−) mice before the development of seizures. Finally, in vitro, we identified that in astrocytes and neurons SPI1 transcription was driven by H(2)O(2)‐induced oxidative stress, independent of mTOR. We identified SPI1/PU.1 as a novel TF involved in the pro‐inflammatory gene expression of malformed cells in TSC and FCD 2b. This transcriptional program is activated in response to oxidative stress and already present prenatally. Importantly, SPI1/PU.1 protein appears to be strictly limited to malformed cells, as we did not find SPI1/PU.1 protein expression in mice nor in our in vitro models.
format Online
Article
Text
id pubmed-8412124
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84121242021-09-03 Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress Zimmer, Till S. Korotkov, Anatoly Zwakenberg, Susan Jansen, Floor E. Zwartkruis, Fried J. T. Rensing, Nicholas R. Wong, Michael Mühlebner, Angelika van Vliet, Erwin A. Aronica, Eleonora Mills, James D. Brain Pathol Research Articles Tuberous sclerosis complex (TSC) is a congenital disorder characterized by cortical malformations and concomitant epilepsy caused by loss‐of‐function mutations in the mTOR suppressors TSC1 or TSC2. While the underlying molecular changes caused by mTOR activation in TSC have previously been investigated, the drivers of these transcriptional change have not been fully elucidated. A better understanding of the perturbed transcriptional regulation could lead to the identification of novel pathways for therapeutic intervention not only in TSC, but other genetic epilepsies in which mTOR activation plays a key role, such as focal cortical dysplasia 2b (FCD). Here, we analyzed RNA sequencing data from cortical tubers and a tsc2(−/−) zebrafish. We identified differential expression of the transcription factors (TFs) SPI1/PU.1, IRF8, GBX2, and IKZF1 of which SPI1/PU.1 and IRF8 targets were enriched among the differentially expressed genes. Furthermore, for SPI1/PU.1 these findings were conserved in TSC zebrafish model. Next, we confirmed overexpression of SPI1/PU.1 on the RNA and protein level in a separate cohort of surgically resected TSC tubers and FCD tissue, in fetal TSC tissue, and a Tsc1 (GFAP−/−) mouse model of TSC. Subsequently, we validated the expression of SPI1/PU.1 in dysmorphic cells with mTOR activation in TSC tubers. In fetal TSC, we detected SPI1/PU.1 expression prenatally and elevated RNA Spi1 expression in Tsc1 (GFAP−/−) mice before the development of seizures. Finally, in vitro, we identified that in astrocytes and neurons SPI1 transcription was driven by H(2)O(2)‐induced oxidative stress, independent of mTOR. We identified SPI1/PU.1 as a novel TF involved in the pro‐inflammatory gene expression of malformed cells in TSC and FCD 2b. This transcriptional program is activated in response to oxidative stress and already present prenatally. Importantly, SPI1/PU.1 protein appears to be strictly limited to malformed cells, as we did not find SPI1/PU.1 protein expression in mice nor in our in vitro models. John Wiley and Sons Inc. 2021-03-30 /pmc/articles/PMC8412124/ /pubmed/33786950 http://dx.doi.org/10.1111/bpa.12949 Text en © 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zimmer, Till S.
Korotkov, Anatoly
Zwakenberg, Susan
Jansen, Floor E.
Zwartkruis, Fried J. T.
Rensing, Nicholas R.
Wong, Michael
Mühlebner, Angelika
van Vliet, Erwin A.
Aronica, Eleonora
Mills, James D.
Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
title Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
title_full Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
title_fullStr Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
title_full_unstemmed Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
title_short Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
title_sort upregulation of the pathogenic transcription factor spi1/pu.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412124/
https://www.ncbi.nlm.nih.gov/pubmed/33786950
http://dx.doi.org/10.1111/bpa.12949
work_keys_str_mv AT zimmertills upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT korotkovanatoly upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT zwakenbergsusan upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT jansenfloore upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT zwartkruisfriedjt upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT rensingnicholasr upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT wongmichael upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT muhlebnerangelika upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT vanvlieterwina upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT aronicaeleonora upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress
AT millsjamesd upregulationofthepathogenictranscriptionfactorspi1pu1intuberoussclerosiscomplexandfocalcorticaldysplasiabyoxidativestress